%D9%83%D8%AB%D8%B1%D8%A9_%D8%A7%D9%84%D9%85%D9%86%D8%B3%D8%AC%D8%A7%D8%AAHistiocitosi%D9%87%DB%8C%D8%B3%D8%AA%DB%8C%DB%86%D8%B3%D8%A7%DB%8C%D8%AA%DB%86%D8%B2%DB%8C%D8%B3Category:HistiocytosesHistiozytoseHistiocytosisHistiocitosisHistiocitoseIstiocitosiHistiocytozaHistiocitoseQ1411740%E7%BB%84%E7%BB%87%E7%BB%86%E8%83%9E%E5%A2%9E%E5%A4%9A%E7%97%87
about
sameAs
H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell HistiocytosisEvaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell HistiocytosisCD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell TransplantationUmbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant DiseasesVemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)PI3K/mTOR Inhibitor LY3023414 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic MalignanciesCeftriaxone in Non-neutropenic FeverProspective Evaluation of Adult Pulmonary Langerhans Cell HistiocytosisAllogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune DeficienciesEvaluation of Outcome of Adult Pulmonary Langerhans Cell Histiocytosis Based on Lung HRCT and Lung FunctionPalbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaProject: Every Child for Younger Patients With CancerPhase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related DisordersMethotrexate and Cytosine in Adult Langerhans Cell HistiocytosisInternational Rare Histiocytic Disorders Registry (IRHDR)A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell HistiocytosisUnrelated Donor Transplant for Malignant and Non-Malignant DisordersCD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor TransplantCollecting and Storing Tissue From Young Patients With CancerSunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyReduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell HistiocytosisStudy of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCHA Combination of Vemurafenib, Cytarabine and 2-chlorodeoxyadenosine in Children With LCH and BRAF V600E MutationDenosumab for the Treatment of Adult LCHA Study of Lenalidomide for Adult Histiocyte DisordersClofarabine for Langerhans in PediCardiovascular Risk Factors and LCH in AdultsVinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)Search Elevated Serum Alkaline Phosphatase as a Marker of Prenatal Intervillositis Chronic Histiocytic
P1050
P2175
Multifocal Rosai-Dorfman disease with involvement of the pinna.Tumor necrosis factor antagonists in the treatment of multicentric reticulohistiocytosis: Current clinical evidenceCytological diagnosis of Langerhans cell histiocytosis: A series of 47 casesKikuchi-Fujimoto Disease: An Atypical Presentation of a Rare DiseaseTreatment of Multifocal Multisystem BRAF Positive Langerhans Cell Histiocytosis with Cladribine, Surgery and Allogenic Stem Cell TransplantationSteroid Induced Cataract in Langerhans Cell Histiocytosis Patient
P921
Q61918224-808B4126-CF50-40FE-B64E-446D1239BD6DQ61955318-E027F075-D533-45BA-9411-51986F8440F6Q61975678-478FE0F9-8E66-45D7-AC39-7A02F357A2BBQ62110734-33CAD189-1D0F-4892-A37A-130447F0948DQ63573040-65D47577-7405-4555-9A85-172E97A74DB0Q63573228-B178C890-688C-4213-8C4B-E6D880CC15A9Q63587860-6CB14998-E8F5-4CF5-8B98-902AB1180FA1Q63807711-DA4321FF-7581-4A7D-897D-CC3009292559Q63807717-98BA551F-01A5-4CE9-B1BE-96B2D75E8F44Q63807718-B4C156F0-18FE-444F-B033-2776BC15470FQ63807719-88C62957-8F4C-4D4B-8253-4C418655A157Q63807720-6AB3B49C-27D7-403E-B530-7D599020B4B3Q63807721-19942596-86A9-4DEA-903F-32B603A7B607Q63807725-D2D62035-18D0-4D7A-B3AB-5951787AC814Q63815432-3F94F7BC-9022-4B85-B385-0E062F259E53Q63817005-4414032E-AC1B-4BC0-9683-6EFF87890B94Q63817023-73626914-9FE3-44B7-8B49-12E00955F6C1Q63838240-569C1C29-5068-4250-B51A-58A04A8B743FQ63838467-601B49DD-1C59-4B43-9713-85C1DE2AF3CFQ64150599-C2F5D4E4-9B75-4F60-94E2-1EA07436ADD7Q64150937-3285C271-F173-4D07-92FB-8A151E8F88A0Q64173073-AE52D060-076E-4F52-8CAB-CCC77E9B20B3Q64351010-F2C2CB7C-20B1-42F6-A126-91B907E099AEQ64395223-53F126E2-A542-4D3D-BA9A-D1D91B855DF1Q64397511-ECDB6D07-EE93-4DCB-8220-BB0FAD05E9D7Q64599760-A02FC474-1EB3-42B0-B511-D1DB78D3153BQ64649580-0B24CD10-DEAA-49B2-B373-B1B51121E408Q64657440-A5E31DDA-5F8B-4568-9A7B-378C21F70039Q64657488-C2967DB2-C57E-40A5-84D3-BD12E6EE835FQ64676309-F597F5EB-AC0E-406A-A4F7-7132C63E0B7FQ64678107-94E0B494-7ABE-4617-94E0-995BC30EF5DAQ64723151-99565622-FE7D-488E-81F1-85A547B85FF1Q64725658-8EA7EC96-95C3-414B-9733-3BD6BA2DC878Q64794763-3FB64C73-2F73-4A33-B667-AFF3309EF714Q64819547-567BA6C7-77C8-45E0-B4DE-9F4FA65AC952Q65338492-51F524A7-08E6-4E3D-8EF1-BEA67773C6B5Q65369493-3068E5A1-2652-4375-B107-84BDAB4F2202Q65381527-922F01C5-AAE8-46DD-9C30-995A0CE9CE07Q65403976-16EB277C-A0D8-4001-A76B-791DD62C47CBQ65465488-D6F9828D-EA45-46A7-B038-2049088D9D8E
P1050
description
Ehunetan ohikoa dena baino his ...... tasunen adierazle izan daiteke
@eu
Krankheit
@de
condizione clinica caratterizz ...... ociti nel sangue e nei tessuti
@it
kwaadaardige woekering van immuuncellen
@nl
lymphatic system disease that is characterized by an excessive number of histiocytes
@en
由组织细胞过量存在引发的症状
@zh
name
Histiocitose
@gl
Histiocytose
@nl
Histiocytoza
@pl
Histiozytose
@de
histiocitose
@pt
histiocitosi
@ca
histiocitosis
@es
histiocytose
@fr
histiocytose
@nn
histiocytosis
@en
type
label
Histiocitose
@gl
Histiocytose
@nl
Histiocytoza
@pl
Histiozytose
@de
histiocitose
@pt
histiocitosi
@ca
histiocitosis
@es
histiocytose
@fr
histiocytose
@nn
histiocytosis
@en
altLabel
Hand Schuller Christian disease
@en
chronic Histiocytosis X
@en
histiocytosis
@nn
組織細胞增生症
@zh
美国组织细胞增生症协会
@zh
prefLabel
Histiocitose
@gl
Histiocytose
@nl
Histiocytoza
@pl
Histiozytose
@de
histiocitose
@pt
histiocitosi
@ca
histiocitosis
@es
histiocytose
@fr
histiocytose
@nn
histiocytosis
@en
P2888
P486
P5806
P6366
P672
P1748
P1995
P2176
P2892
P31
P373
Histiocytoses
P3841
HP:0100727
P4746
P486
P5270
MONDO:0002637
P5806
P604
P6366
2780174970
P672
C15.604.250